Mhc-matched corneal allograft rejection in an ifn-γ/il-17-independent manner in C57BL/6 mice

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 5, 2009, Pages 2139-2146

  Yamada, Jun ^a   Hamuro, Junji ^b   Fukushima, Atsuki ^c   Ohteki, Toshiaki ^d   Terai, Kazuto ^a   Iwakura, Yoichiro ^e   Yagita, Hideo ^f   Kinoshita, Shigeru ^b  

^a MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

^d AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CELL ANTIGEN; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GLYCOPROTEIN P 15095; INTERLEUKIN 17; INTERLEUKIN 6; MESSENGER RNA; PROTEIN GR 1; RNA; UNCLASSIFIED DRUG; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CERVICAL LYMPH NODE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORNEA STROMA; CORNEA TRANSPLANTATION; EOSINOPHIL; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HLA MATCHING; KNOCKOUT MOUSE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION; WILD TYPE; ALLOTRANSPLANTATION; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; DELAYED HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; B-LYMPHOCYTES; CELL PROLIFERATION; CORNEAL TRANSPLANTATION; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; GRAFT REJECTION; GRAFT SURVIVAL; HYPERSENSITIVITY, DELAYED; INTERFERON-GAMMA; INTERLEUKIN-17; MACROPHAGES; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MINOR HISTOCOMPATIBILITY ANTIGENS; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 65549122578     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2993     Document Type: Article

References (53)

1. Bromberg JS, Murphy B. Routes to allograft survival. J Clin Invest. 2001;107(7):797-798.
2. Hargrave SL, Hay C, Mellon J, Mayhew E, Niederkorn JY. Fate of MHC-matched corneal allografts in Th1-deficient hosts. Invest Ophthalmol Vis Sci. 2004;45(4):1188-1193.
3. Volker-Dieben HJ, Schreuder GM, Claas FH, et al. Histocompatibility and corneal transplantation. Dev Ophthalmol. 2003;36:22-41.
4. Reinhard T, Bohringer D, Enczmann J, et al. HLA class I and II matching improves prognosis in penetrating normal-risk keratoplasty. Dev Ophthalmol. 2003;36:42-49.
5. The Collaborative Corneal Transplantation Studies Research Group. The collaborative corneal transplantation studies (CCTS): effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol. 1992;110(10):1392-1403.
6. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice: evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992;54(4):694-704.
7. Sano Y, Ksander BR, Streilein JW. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. Transplant Immunol. 1996;4(1):53-56.
8. Yamada J, Streilein JW. Fate of orthotopic corneal allografts in C57BL/6 mice. Transplant Immunol. 1998;6(3):161-168.
9. Waaga AM, Gasser M, Kist-van Holthe JE, et al. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J Clin Invest. 2001;107(7):909-916.
10. Yamada J, Yoshida M, Taylor AW, Streilein JW. Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in "high risk" eyes. J Immunol. 1999;162(9):5247-5255.
11. Papadakis KA, Zhu D, Prehn JL, et al. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9 T lymphocytes. J Immunol. 2005;174(8):4985-4990.
12. Yoshimoto T, Takeda K, Tanaka T, et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol. 1998;161(7): 3400-3407.
13. Ahn HJ, Maruo S, Tomura M, et al. A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in en-hanced production of IFN-gamma. J Immunol. 1997;159(5):2125-2131.
14. Chang JT, Segal BM, Nakanishi K, Okamura H, Shevach EM. The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit. EurJ Immunol. 2000;30(4):1113-1119.
15. Obara H, Nagasaki K, Hsieh CL, et al. IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses. Am J Transplant. 2005;5(9):2094-2103.
16. Katami M. Corneal transplantation-immunologically privileged status. Eye. 1991;5(5):528-548.
17. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993;259(5102):1739-1742.
18. Swihart K, Fruth U, Messmer N, et al. Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4 T cell response. J Exp Med. 1995;181(3):961-971.
19. Nakae S, Komiyama Y, Nambu A, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 2002; 17(3):375-387.
20. Schwarzenberger P, La Russa V, Miller A, et al. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapyderived method for in vivo evaluation of cytokines. J Immunol. 1998;161(11):6383-6389.
21. Hori J, Joyce NC, Streilein JW. Immune privilege and immunogenicity reside among different layers of the mouse cornea. Invest Ophthalmol Vis Sci. 2000;41(10):3032-3042.
22. Klebe S, Coster DJ, Sykes PJ, et al. Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine IL-12-p40 but not IL-4 to donor corneal endothelium. J Immunol. 2005; 175(4):2219-2226.
23. Beauregard C, Stevens C, Mayhew E, Niederkorn JY. Cutting edge: atopy promotes Th2 responses to alloantigens and increases the incidence and tempo of corneal allograft rejection. J Immunol. 2005;174(11):6577-6581.
24. Hidalgo LG, Halloran PF. Role of IFN-gamma in allograft rejection. Crit Rev Immunol. 2002;22(4):317-349.
25. Halloran PF, Afrouzian M, Ramassar V, et al. Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis. Am J Pathol. 2001;158(1):215-226.
26. Halloran PF, Miller LW, Urmson J, et al. IFN-gamma alters the pathology of graft rejection: protection from early necrosis. J Immunol. 2001;166(12):7072-7081.
27. Fallarino F, Grohmann U, Hwang KW, et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. 2003;4(12): 1206-1212.
28. Zhang J. Yin and yang interplay of IFN-gamma in inflammation and autoimmune disease. J Clin Invest. 2007;117(4):871-873.
29. Wang Z, Hong J, Sun W, et al. Role of IFN-gamma in induction of Foxp3 and conversion of CD4 CD25- T cells to CD4 Tregs. J Clin Invest. 2006;116(9):2434-2441.
30. Sawitzki B, Kingsley CI, Oliveira V, Karim M, Herber M, Wood KJ. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med. 2005; 201(12):1925-1935.
31. Guillonneau C, Hill M, Hubert FX, et al. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN- gamma, and indoleamine 2,3-dioxygenase. J Clin Invest. 2007; 117(4):1096-1106.
32. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007;13(2):139-145.
33. Nakae S, Suto H, Berry GJ, Galli SJ. Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood. 2007;109(9):3640-3648.
34. Nakae S, Iwakura Y, Suto H, Galli SJ. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukocyte Biol. 2007;81(5):1258-1268.
35. Lubberts E. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?. Cytokine. 2008;41(2):84-91.
36. Lim HW, Lee J, Hillsamer P, Kim CH. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3 regulatory T cells. J Immunol. 2008;180(1):122-129.
37. Su SB, Grajewski RS, Luger D, et al. Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency. Invest Ophthalmol Vis Sci. 2007;48(10):4616-4625.
38. Cox CA, Shi G, Yin H, et al. Both Th1 and Th17 are immunopathogenic but differ in other key biological activities. J Immunol. 2008;180(11):7414-7422.
39. Luger D, Silver PB, Tang J, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med. 2008;205(4):799-810.
40. Kobayashi T, Okamoto S, Hisamatsu T, et al. IL-23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut. 2008;57(12):1682-1689.
41. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol. 2007;148(1): 32-46.
42. Jones LS, Rizzo LV, Agarwal RK, et al. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J Immunol. 1997;158(12):5997-6005.
43. Flynn TH, Ohbayashi M, Ikeda Y, Ono SJ, Larkin DF. Effect of allergic conjunctival inflammation on the allogeneic response to donor cornea. Invest Ophthalmol Vis Sci. 2007;48(9):4044-4049.
44. Bishop DK, Chan Wood S, Eichwald EJ, Orosz CG. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8 effector cells develop independently of CD4 cells and CD40-CD40 ligand interactions. J Immunol. 2001;166(5):3248-3255.
45. El-Sawy T, Miura M, Fairchild R. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis. Am J Pathol. 2004;165(1): 147-157.
46. Miura M, El-Sawy T, Fairchild RL. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma. Am J Pathol. 2003;162(2):509-519.
47. Surquin M, Le Moine A, Flamand V, et al. IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts. Transplantation. 2005;80(10):1485-1492.
48. Forlow SB, Schurr JR, Kolls JK, Bagby GJ, Schwarzenberger PO, Ley K. Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion moleculedeficient mice. Blood. 2001;98(12):3309-3314.
49. Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J, Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol. 2003; 170(9):4665-4672.
50. George-Chandy A, Nordstrom I, Nygren E, et al. Th17 development and autoimmune arthritis in the absence of reactive oxygen species. Eur J Immunol. 2008;38(4):1118-1126.
51. Ohteki T, Fukao T, Suzue K, et al. Interleukin 12-dependent interferon gamma production by CD8alpha lymphoid dendritic cells. J Exp Med. 1999;189(12):1981-1986.
52. Yamada J, Maruyama K, Sano Y, Kinoshita S, Murata Y, Hamuro J. Promotion of corneal allograft survival by the induction of oxidative macrophages. Invest Ophthalmol Vis Sci. 2004;45(2):448-454.
53. Yamada J, Hamuro J, Terai K, Kinoshita S. Major histocompatibility complex semi-matching improves murine corneal allograft survival under oxidative macrophage dominancy. Transplantation. 2007; 84(7):899-907.